Systemic therapy: blood-brain barrier
Gerstner et al. Nat Rev Clin Oncol 2009
Tumor-derived
mediators of BBB
disruption:
• VEGF
• Nitric oxide (NO)
• Leukotrienes
• Prostaglandins